Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A carcinoma that arises from epithelial cells of the extrahepatic bile duct.
Biomarker and diagnostic research for extrahepatic bile duct carcinoma has been reported in the published literature.
3 clinical trials registered. Interventions under study include other interventions, procedural interventions, drug therapy, and biologic therapy. Pipeline includes 1 PHASE2, 1 NA. Research is primarily sponsored by academic and government institutions.
27 publications have been identified in PubMed for extrahepatic bile duct carcinoma. Research spans Epidemiology / Natural History (44%), Review / Meta-Analysis (19%), and Diagnostic / Biomarker (15%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 12 |
Data assembled from 3 of 12 sources · Last updated Sep 19, 2026, 2:54 PM UTC
44%
Research summaries | 5 | 19% |
Testing and diagnosis research | 4 | 15% |
Patient case studies | 3 | 11% |
Laboratory research | 2 | 7% |
Clinical study results | 1 | 4% |
Oh MH (2026). [PMID: 41242700](https://pubmed.ncbi.nlm.nih.gov/41242700/). *Ann Hepatobiliary Pancreat Surg*. [Diagnostic / Biomarker]
Kim JY (2026). [PMID: 41484473](https://pubmed.ncbi.nlm.nih.gov/41484473/). *Virchows Arch*. [Epidemiology / Natural History]
Wang Z (2026). [PMID: 42030695](https://pubmed.ncbi.nlm.nih.gov/42030695/). *Eur J Surg Oncol*. [Epidemiology / Natural History]
Unknown (2026). [PMID: 42027161](https://pubmed.ncbi.nlm.nih.gov/42027161/). *Khirurgiia (Mosk)*. [Clinical Trial Publication]
Kang MJ (2026). [PMID: 41677333](https://pubmed.ncbi.nlm.nih.gov/41677333/). *Int J Surg*. [Epidemiology / Natural History]
Kim JS (2026). [PMID: 41702441](https://pubmed.ncbi.nlm.nih.gov/41702441/). *Int J Radiat Oncol Biol Phys*. [Epidemiology / Natural History]
Bhattacharjee PS (2026). [PMID: 41733071](https://pubmed.ncbi.nlm.nih.gov/41733071/). *Cancer*. [Epidemiology / Natural History]
Miwa H (2026). [PMID: 40458535](https://pubmed.ncbi.nlm.nih.gov/40458535/). *DEN Open*. [Case Report / Case Series]
Zhai A (2025). [PMID: 41137215](https://pubmed.ncbi.nlm.nih.gov/41137215/). *Medicine (Baltimore)*. [Review / Meta-Analysis]
Kwon YJ (2025). [PMID: 39586759](https://pubmed.ncbi.nlm.nih.gov/39586759/). *HPB (Oxford)*. [Diagnostic / Biomarker]